TAKEDA PHARMACEUTICAL CO LTD·4

Apr 28, 6:06 AM ET

Ricci Gabriele 4

4 · TAKEDA PHARMACEUTICAL CO LTD · Filed Apr 28, 2026

Research Summary

AI-generated summary of this filing

Updated

Takeda (TAK) Chief Data & Tech Officer Gabriele Ricci Receives Award

What Happened
Gabriele Ricci, Takeda's Chief Data & Technology Officer, was awarded 34,994 restricted stock units (RSUs) on April 27, 2026. The Form 4 reports an acquisition (code A) of 34,994 shares at $0.00 (award/grant). These RSUs are contingent rights to receive American Depositary Shares (ADS) once vesting conditions are met.

Key Details

  • Transaction date: April 27, 2026; Form 4 filed April 28, 2026 (appears timely).
  • Reported transaction: Grant/Award (code A) of 34,994 RSUs at $0.00 (total reported acquisition value $0).
  • Footnote F1: The award ties back to a July 1, 2023 performance-based RSU grant; the Compensation Committee determined payout on April 27, 2026 based on performance metrics (core revenue, core operating profit, R&D milestones).
  • Footnote F2: The filing notes a total of 80,768 RSUs included for the reporting person; these RSUs vest as ADSs on July 1, 2026 (56,946), July 1, 2027 (16,012) and July 1, 2028 (7,810).
  • What this means: RSUs are contingent equity awards (not an open-market purchase or sale) and convert to ADSs upon vesting; the filing does not report immediate cash value or sale.

Context
This filing documents a performance-based equity award rather than an open-market trade. For retail investors, awards like this indicate company compensation tied to long-term performance metrics; they do not by themselves indicate insider buying or selling of existing shares.

Insider Transaction Report

Form 4
Period: 2026-04-27
Ricci Gabriele
Chief Data & Tech. Officer
Transactions
  • Award

    American Depositary Shares

    [F1][F2]
    2026-04-27+34,994159,126 total
Footnotes (2)
  • [F1]On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones. On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above.
  • [F2]Includes 80,768 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (56,946 shares), July 1, 2027 (16,012 shares) and July 1, 2028 (7,810 shares).
Signature
/s/ Max Heuer, by power of attorney, for Gabriele Ricci|2026-04-27

Documents

1 file
  • 4
    wk-form4_1777370797.xmlPrimary

    FORM 4